Scientists of the Research Center caesar in Bonn, an Institute of the Max Planck Society, developed a new biosensor, which allows to measure nanomolar levels of the second messenger cAMP. The sensor makes it possible to study cAMP signaling with high precision, even in subcellular compartments. Using this new biosensor, the scientists of the Minerva Max Planck Research Group “Molecular Physiology“ headed by Dagmar Wachten and of the Department “Molecular Sensory Systems” headed by Benjamin Kaupp revealed how the production of cAMP is regulated in the flagella of sperm cells from mice.
Yissum Research Development Company of the Hebrew University of Jerusalem, the technology-transfer company of the Hebrew University, announced today the formation of Neteera Technologies, developer of remote sensing technology of various human biological indicators. Neteera Technologies has completed its first round of funding, raising $2.0 million from private investors.
Researchers from the University of Illinois at Urbana-Champaign have developed a highly sensitive biosensor based on a differential immuno-capture technology that can detect sub-populations of white blood cells. As part of a small, disposable biochip, the microfluidic biosensor can count CD4+/CD8+ T cells quickly and accurately for AIDS diagnosis in the field. This is a follow-up of the work earlier published by the group in Science Translational Medicine.
A portable biosensor that could show how disease is progressing in patients with Alzheimer’s could greatly improve people’s quality of life in the future, according to a new review published in Biosensors and Bioelectronics.
BIO-key International, Inc., an innovative provider of strong, interoperable biometric authentication solutions, announced that ten of the company's healthcare partners will be highlighting BIO-key solutions at the HIMSS 2016 event February 29th - March 4th, to be held at the Sands Conference Center, Las Vegas, Nevada. Over 35,000 healthcare IT professionals will attend the four day educational and networking event.
Goodix, a world leader in innovative human interface solutions for mobile devices, announced three new technologies at Mobile World Congress 2016 in Barcelona, including the world’s first Live Finger Detection™ technology to enhance security; the force-sensitive Newton Touch™ panel, and an ultra-low power heart rate sensor, which enables smart earphone with heart rate detection capability.
Royal Philips today announced that it will introduce a next-generation monitoring solution for at-risk patients in low acuity hospital settings, such as the general ward. As an industry-first, the new medical-grade biosensor enabled solution demonstrates Philips' continuing commitment to better addressing clinicians' and patients' needs through monitoring.
Egis Technology Inc., a leading fingerprint sensor provider, will be promoting their newest lineup of fingerprint IC sensors, authentication solutions, mobile payment solutions based on FIDO specifications and PKI as well as their FIDO Certified™ UAF & U2F products at MWC Barcelona from the 22nd of February to the 25th of February at their booth, 7K20, in Hall 7.
BIO-key International, Inc., an innovative provider of strong interoperable biometric authentication solutions, announced that the company has combined IDEX's advanced off-chip sensor technology with BIO-key's NIST-tested universal Windows Biometric Framework (WBF) fingerprint engine, to introduce a USB fingerprint reader that operates on both Windows and Android platforms.
Synaptics Incorporated, the leading developer of human interface solutions, today announced the Natural ID™ FS4304, an ultra-slim area-touch biometric fingerprint sensor designed with industrial design flexibility to fit small spaces including the edge of smartphones or tablets.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.